in addition the potential role of therapy with somatostatin analogs and the preliminary effects of somatostatin and/or sms 201-995 are discussed in disorders of gastro-intestinal function ( haemorrhages , diarrhoea , pancreatitis and endocrine pancreatic tumours ) , diabetes mellitus , central nervous system disturbances and oncology .
C0030274
pancreatic
C0011849
diabetes mellitus